Manuel Anderegg

736 total citations
22 papers, 498 citations indexed

About

Manuel Anderegg is a scholar working on Molecular Biology, Genetics and Nephrology. According to data from OpenAlex, Manuel Anderegg has authored 22 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Nephrology. Recurrent topics in Manuel Anderegg's work include Ion Transport and Channel Regulation (7 papers), Genetic and Kidney Cyst Diseases (6 papers) and Kidney Stones and Urolithiasis Treatments (4 papers). Manuel Anderegg is often cited by papers focused on Ion Transport and Channel Regulation (7 papers), Genetic and Kidney Cyst Diseases (6 papers) and Kidney Stones and Urolithiasis Treatments (4 papers). Manuel Anderegg collaborates with scholars based in Switzerland, Italy and United States. Manuel Anderegg's co-authors include Daniel G. Fuster, Bruno Vogt, Stefano F. Rimoldi, Elisa Bouillet, Urs Scherrer, Uyen Huynh‐Do, Ariane Paoloni‐Giacobino, Giuseppe Albano, Cláudio Sartori and Emmanuel Somm and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Manuel Anderegg

22 papers receiving 491 citations

Peers

Manuel Anderegg
Irene Yam China
Manuel Anderegg
Citations per year, relative to Manuel Anderegg Manuel Anderegg (= 1×) peers Irene Yam

Countries citing papers authored by Manuel Anderegg

Since Specialization
Citations

This map shows the geographic impact of Manuel Anderegg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Anderegg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Anderegg more than expected).

Fields of papers citing papers by Manuel Anderegg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Anderegg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Anderegg. The network helps show where Manuel Anderegg may publish in the future.

Co-authorship network of co-authors of Manuel Anderegg

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Anderegg. A scholar is included among the top collaborators of Manuel Anderegg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Anderegg. Manuel Anderegg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anderegg, Manuel, Matteo Bargagli, Lia Bally, et al.. (2025). Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trial. Nature Medicine. 31(1). 286–293. 6 indexed citations
2.
Bargagli, Matteo, Manuel Anderegg, & Daniel G. Fuster. (2024). Effects of thiazides and new findings on kidney stones and dysglycemic side effects. Acta Physiologica. 240(7). e14155–e14155. 2 indexed citations
3.
Anderegg, Manuel, Eric Olinger, Matteo Bargagli, et al.. (2024). Prevalence and characteristics of genetic disease in adult kidney stone formers. Nephrology Dialysis Transplantation. 39(9). 1426–1441. 19 indexed citations
4.
Albano, Giuseppe, Matteo Bargagli, Manuel Anderegg, et al.. (2023). Thiazides Attenuate Insulin Secretion Through Inhibition of Mitochondrial Carbonic Anhydrase 5b in β-Islet Cells in Mice. Journal of the American Society of Nephrology. 34(7). 1179–1190. 6 indexed citations
5.
Anderegg, Manuel, Andreas Limacher, Michael P. Horn, et al.. (2022). Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients. RMD Open. 8(1). e002036–e002036. 35 indexed citations
6.
Ferraro, Pietro Manuel, Matteo Bargagli, Manuel Anderegg, et al.. (2022). The role of urinary supersaturations for lithogenic salts in the progression of autosomal dominant polycystic kidney disease. Journal of Nephrology. 36(4). 1011–1018. 3 indexed citations
7.
8.
Bargagli, Matteo, Manuel Anderegg, Pietro Manuel Ferraro, & Daniel G. Fuster. (2022). Altered Lipid Metabolism in Autosomal Dominant Polycystic Kidney Disease Patients Treated With Tolvaptan. Journal of the American Society of Nephrology. 33(11S). 160–161. 2 indexed citations
9.
Bargagli, Matteo, Manuel Anderegg, Nasser A. Dhayat, et al.. (2022). Tolvaptan treatment is associated with altered mineral metabolism parameters and increased bone mineral density in ADPKD patients. Nephrology Dialysis Transplantation. 38(7). 1645–1654. 3 indexed citations
10.
Bargagli, Matteo, Pietro Manuel Ferraro, Nasser A. Dhayat, Manuel Anderegg, & Daniel G. Fuster. (2021). Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients. Kidney International Reports. 6(6). 1749–1749. 2 indexed citations
11.
Albano, Giuseppe, Silvia Dolder, Mark Siegrist, et al.. (2021). Deletion of the sodium/hydrogen exchanger 6 causes low bone volume in adult mice. Bone. 153. 116178–116178. 2 indexed citations
12.
Anderegg, Manuel, Michael Liu, Matteo Montani, et al.. (2021). De novo vasculitis after mRNA-1273 (Moderna) vaccination. Kidney International. 100(2). 474–476. 68 indexed citations
13.
Bargagli, Matteo, Nasser A. Dhayat, Manuel Anderegg, et al.. (2020). Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan. Clinical Journal of the American Society of Nephrology. 15(7). 1007–1014. 16 indexed citations
14.
Anderegg, Manuel, Nasser A. Dhayat, Grit Sommer, et al.. (2020). Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients Treated With Tolvaptan. Kidney Medicine. 2(2). 162–171. 15 indexed citations
15.
Anderegg, Manuel, Giuseppe Albano, Dominik E. Uehlinger, et al.. (2020). The sodium/proton exchanger NHA2 regulates blood pressure through a WNK4-NCC dependent pathway in the kidney. Kidney International. 99(2). 350–363. 15 indexed citations
16.
Pathare, Ganesh, Manuel Anderegg, Giuseppe Albano, Florian Läng, & Daniel G. Fuster. (2018). Elevated FGF23 Levels in Mice Lacking the Thiazide-Sensitive NaCl cotransporter (NCC). Scientific Reports. 8(1). 3590–3590. 18 indexed citations
17.
Dhayat, Nasser A., Ganesh Pathare, Manuel Anderegg, et al.. (2017). Furosemide/Fludrocortisone Test and Clinical Parameters to Diagnose Incomplete Distal Renal Tubular Acidosis in Kidney Stone Formers. Clinical Journal of the American Society of Nephrology. 12(9). 1507–1517. 33 indexed citations
18.
Anderegg, Manuel, et al.. (2016). Neuropilin1 regulates glomerular function and basement membrane composition through pericytes in the mouse kidney. Kidney International. 91(4). 868–879. 15 indexed citations
19.
Anderegg, Manuel, Giuseppe Albano, Bernhard Lüscher, et al.. (2016). Loss of Sodium/Hydrogen Exchanger NHA2 Exacerbates Obesity- and Aging-Induced Glucose Intolerance in Mice. PLoS ONE. 11(9). e0163568–e0163568. 12 indexed citations
20.
Simonin, Alexandre, Manuel Anderegg, Giuseppe Albano, et al.. (2013). Sodium/hydrogen exchanger NHA2 is critical for insulin secretion in β-cells. Proceedings of the National Academy of Sciences. 110(24). 10004–10009. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026